These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3939486)

  • 1. Use of the CaNa2 EDTA Pb-mobilization test to detect occult lead nephropathy.
    Wedeen RP
    Uremia Invest; 1985-1986; 9(2):127-30. PubMed ID: 3939486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead nephropathy.
    Wedeen RP; D'Haese P; Van de Vyver FL; Verpooten GA; De Broe ME
    Am J Kidney Dis; 1986 Nov; 8(5):380-3. PubMed ID: 3098095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult lead intoxication in patients with gout and kidney disease.
    Wright LF; Saylor RP; Cecere FA
    J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic lead poisoning: Lead gout with giant tophi on the skin, nephrophathy and porphyrinopathy].
    Orfanos CE; Künzig M
    Hautarzt; 1975 Nov; 26(11):581-4. PubMed ID: 812845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead nephropathy, gout, and hypertension.
    Batuman V
    Am J Med Sci; 1993 Apr; 305(4):241-7. PubMed ID: 8475950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lead accumulation as a possible cause of renal failure in gouty patients.
    Colleoni N; D'Amico G
    Nephron; 1986; 44(1):32-5. PubMed ID: 3092121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead and the kidney: nephropathy, hypertension, and gout.
    Perazella MA
    Conn Med; 1996 Sep; 60(9):521-6. PubMed ID: 8908777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lead in renal failure.
    Wedeen RP
    Clin Exp Dial Apheresis; 1982; 6(2-3):113-46. PubMed ID: 6758998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult lead intoxication as a cause of hypertension and renal failure.
    Sánchez-Fructuoso AI; Torralbo A; Arroyo M; Luque M; Ruilope LM; Santos JL; Cruceyra A; Barrientos A
    Nephrol Dial Transplant; 1996 Sep; 11(9):1775-80. PubMed ID: 8918621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of zinc in urine at the use of CaNa2 EDTA in workers exposed to lead].
    Durić D; Bojović V; Graovac-Leposavić L; Milić S
    Arh Hig Rada Toksikol; 1969; 20(4):687-91. PubMed ID: 4992051
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of lead excretion in patients with gout and chronic renal failure--a comparative German and Australian study.
    Craswell PW; Price J; Boyle PD; Behringer D; Stoeppler M; Ritz E
    Sci Total Environ; 1987 Oct; 66():17-28. PubMed ID: 3120309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of occupational lead poisoning by slow subcutaneous administration of CaNa2 EDTA.
    Cicchella G; Arcangeli G; Rizzardini L
    Sci Total Environ; 1988 Jun; 71(3):551-2. PubMed ID: 3136544
    [No Abstract]   [Full Text] [Related]  

  • 13. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
    G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary lead excretion in uremic patients.
    Behringer D; Craswell P; Mohl C; Stoeppler M; Ritz E
    Nephron; 1986; 42(4):323-9. PubMed ID: 3083277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of the diagnostic sodium calcium edetate mobilization test as a criterion of lead absorption.
    Lahaye D; Everaet E; Roosels D
    J Soc Occup Med; 1989; 39(4):136-40. PubMed ID: 2516184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with oral and parenteral use of CaNa2 EDTA].
    Vasiljević S; Filipović DK; Andjelovski A
    Arh Hig Rada Toksikol; 1969; 20(4):679-86. PubMed ID: 4992050
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone lead, hypertension, and lead nephropathy.
    Wedeen RP
    Environ Health Perspect; 1988 Jun; 78():57-60. PubMed ID: 3203647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic renal failure with gout: a marker of chronic lead poisoning.
    Craswell PW; Price J; Boyle PD; Heazlewood VJ; Baddeley H; Lloyd HM; Thomas BJ; Thomas BW
    Kidney Int; 1984 Sep; 26(3):319-23. PubMed ID: 6439940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHRONIC LEAD NEPHROPATHY: THE DIAGNOSTIC USE OF CALCIUM EDTA AND THE ASSOCIATION WITH GOUT.
    EMMERSON BT
    Australas Ann Med; 1963 Nov; 12():310-24. PubMed ID: 14078907
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution of lead to hypertension with renal impairment.
    Batuman V; Landy E; Maesaka JK; Wedeen RP
    N Engl J Med; 1983 Jul; 309(1):17-21. PubMed ID: 6406892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.